Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Association of sleep duration and sleep quality with metabolic associated fatty liver disease among Wuhan subway workers

Published on New Medicine 2025,35(11):1256-1264.
2237 times 416 times

PENG Rong LIU Junling SHI Bin TAO Yi YAN Xueping HE Zhenyu

Sleep duration Sleep quality Metabolic associated fatty liver disease Mediation effect
Details
Investigation and implementation exploration on knowledge, attitude and practice of influenza vaccination among college students

Published on New Medicine 2025,35(11):1249-1255.
2504 times 489 times

XUE Lijia NIE Ying WANG Wei WANG Lu LIU Hongjun LUO Shihuan LI Nan ZOU Xinyu LI Sheyu LUO Li

Influenza Vaccination College students Knowledge attitude and practice Influencing factors
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
1961 times 343 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details
Anti-infection treatment and pharmaceutical care for a patient with liver cirrhosis complicated with severe psittacosis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1340-1346.
1966 times 361 times

XING Baiqian LIU Hunan SUN Yihong LU Nianfang LI Zhongdong

Liver cirrhosis Chlamydia psittaci Omadacycline Voriconazole Posaconazole Pharmaceutical care
Details
Pharmaceutical practice of bevacizumab-induced refractory hypertension and proteinuria in a patient with advanced lung adenocarcinoma

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1335-1339.
1855 times 345 times

YAN Jiaju YUAN Yongyong LIU Meng

Bevacizumab Lung adenocarcinoma Resistant hypertension Proteinuria Phamaceutical care
Details
Pharmaceutical care for a case of abemaciclib-induced interstitial lung disease

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1330-1334.
1816 times 346 times

DING Liping WU Wei WANG Chunhui

Abemaciclib Interstitial lung disease Breast cancer Pharmaceutical care
Details
Research advances in adverse drug reactions and their management in targeted therapy for driver gene-positive advanced non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1320-1329.
1973 times 357 times

FAN Jiameng PAN Lei

Non-small cell lung cancer Target therapy Adverse drug reactions Symptom management Biomarker
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
1927 times 357 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
1874 times 359 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1294-1301.
2449 times 485 times

LU Ronghua LIU Jiaojiao PANG Tengfei CAI Rui YUAN Jian

Tegoprazan Gastroesophageal reflux disease Meta-analysis Systematic review Randomized controlled trial
Details
Analysis on the burden and trend of musculoskeletal diseases in China based on GBD 2021

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1283-1293.
2113 times 426 times

ZHAO Duowei WEI Jiantong JIANG Jin XU Shenggang ZHANG Hui

Musculoskeletal diseases Gout Osteoarthritis Rheumatoid arthritis Low back pain Neck pain Burden of disease Changing trend
Details
Analysis of the correlation between medication regimen complexity and glycemic control among type 2 diabetes mellitus in the elderly

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1276-1282.
1940 times 389 times

ZHI Junna QU Guohong WU Ling TAN Zhen

Medication regimen complexity Elderly Type 2 diabetes mellitus Glycemic control
Details
Insights on facilitators and barriers to regulating non-medical use of prescription opioids: a qualitative study

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1265-1275.
2200 times 380 times

DUAN Yuehan ZHOU Huziwei YANG Yingzi WEN Qiaorui CHU Hongling WANG Jingling JIANG Zhiqin SUN Yexiang ZHU Yu WANG Shengfeng

Opioid Non-medical use Drug abuse Substance addiction Drug regulation Qualitative study
Details
Influencing factors for the duration of prophylactic antibacterial therapy in patients with total hip arthroplasty

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1244-1251.
1926 times 390 times

FAN Xinxing XIONG Jian LI Lunjin LIU Xiao YANG Zhiyong SHI Zheng

Total hip arthroplasty Antibiotics Prophylaxis Course of treatment Influencing factors
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (11): introduction and examples of pharmacovigilance impact research

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1233-1243.
2120 times 477 times

NIE Xiaolu SONG Haibo REN Jingtian YAN Jinan WU Jiarui ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guidelines Pharmacovigilance impact research
Details
Systematic biological study on traditional Chinese medicine treatment for non-alcoholic fatty liver disease: analysis of compatibility patterns and multi-target synergistic mechanisms

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1878-1886.
3063 times 408 times

ZHANG Zhenwei ZHANG Nana ZHANG Hua SHI Lei YU Qiuxiang

Non-alcoholic fatty liver disease Network pharmacology Molecular mechanism Chemical components of traditional Chinese medicine Collaborative efficiency enhancement
Details
Research progress on the mechanism of physiological and pathological cardiac hypertrophy and the intervention of traditional Chinese medicine

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1954-1964.
2707 times 378 times

ZHOU Shiguo HE Wenjie CHEN Pingping LU Fang

Cardiac hypertrophy Physiological and pathological Molecular regulation mechanism Signaling pathway Chinese medicine intervention mTOR PGC-1α miRNA
Details
Clinical study on the combination of wentong guasha with herbal enema in improving acute attack of chronic pelvic inflammatory disease

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1258-1264.
2614 times 545 times

LIU Li FENG Jinping OU Yuyi OU Huizhi ZHANG Ying HE Siyuan LIU Shuai LYU Jun

Chronic pelvic inflammatory disease Acute attack Wentong guasha Herbal enema
Details
Application of evidence-based medicine teaching model in clinical education

Published on Journal of Mathematical Medicine 2025,38(10):793-799.
2640 times 492 times

HAO Zhuowen WANG Ying LI Jingfeng

Evidence-based medicine Teaching model Clinical teaching Standardized residency training Teaching methods
Details
Combined laparoscopic and endoscopic treatment of gastric schwannoma: a case report

Published on Journal of Mathematical Medicine 2025,38(10):787-792.
2300 times 482 times

ZOU Jingjie XIAO Fei

Gastric schwannoma Laparoscopic and endoscopic cooperative surgery Immunohistochemistry
Details